These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14598079)

  • 1. Progressive supranuclear palsy: analysis of six cases.
    Marra M; Toni V; Trianni G; Coppola G
    Neurol Sci; 2003 Oct; 24(3):186-7. PubMed ID: 14598079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history and clinical features of progressive supranuclear palsy: a clinical study.
    Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G
    Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal presentation in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Kamphorst W; Ravid R; Duivenvoorden HJ; van Swieten JC
    Neurology; 2007 Aug; 69(8):723-9. PubMed ID: 17709703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic stimulation improves levodopa responsive symptoms in a case of progressive supranuclear palsy.
    Bergmann KJ; Salak VL
    Parkinsonism Relat Disord; 2008; 14(4):348-52. PubMed ID: 17825599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases.
    Birdi S; Rajput AH; Fenton M; Donat JR; Rozdilsky B; Robinson C; Macaulay R; George D
    Mov Disord; 2002 Nov; 17(6):1255-64. PubMed ID: 12465065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive supranuclear palsy (PSP)].
    Nishimiya J; Yuasa T
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):45-8. PubMed ID: 10434587
    [No Abstract]   [Full Text] [Related]  

  • 8. Health-related quality of life in patients with progressive supranuclear palsy.
    Schrag A; Selai C; Davis J; Lees AJ; Jahanshahi M; Quinn N
    Mov Disord; 2003 Dec; 18(12):1464-9. PubMed ID: 14673883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.
    Yamauchi H; Fukuyama H; Nagahama Y; Katsumi Y; Dong Y; Konishi J; Kimura J
    Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive supranuclear palsy.
    Duvoisin RC; Golbe LI; Lepore FE
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):547-54. PubMed ID: 3315157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy.
    Esper CD; Weiner WJ; Factor SA
    Rev Neurol Dis; 2007; 4(4):209-16. PubMed ID: 18195676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological features of progressive supranuclear palsy.
    Grafman J; Litvan I; Stark M
    Brain Cogn; 1995 Aug; 28(3):311-20. PubMed ID: 8546857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease.
    Cordato NJ; Halliday GM; Caine D; Morris JG
    Mov Disord; 2006 May; 21(5):632-8. PubMed ID: 16353177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of clinical diagnosis of progressive supranuclear palsy.
    Osaki Y; Ben-Shlomo Y; Lees AJ; Daniel SE; Colosimo C; Wenning G; Quinn N
    Mov Disord; 2004 Feb; 19(2):181-9. PubMed ID: 14978673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review.
    Tashiro K; Ogata K; Goto Y; Taniwaki T; Okayama A; Kira J; Tobimatsu S
    Clin Neurophysiol; 2006 Oct; 117(10):2236-42. PubMed ID: 16920021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limb apraxia and cognitive impairment in progressive supranuclear palsy.
    Soliveri P; Piacentini S; Girotti F
    Neurocase; 2005 Aug; 11(4):263-7. PubMed ID: 16093226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.